Drugs Health Medical

US regulator clears Mirum’s oral drug for reducing cholesterol deposits

Mirum Pharmaceuticals Inc.’s oral cholesterol drug for treating a rare metabolic disease has been approved by the Food and Drug Administration.

Read More
Pharma

Eli Lilly’s pill for genetic high cholesterol cuts risk by 86% in trial 2

HQ Team November 19, 2024: Eli Lilly announced promising results from its Phase 2 clinical trial of muvalaplin, an oral medication designed to.

Read More
Drugs Health Pharma

Simple blood tests can map women’s heart disease risks when done early

A simple blood test — done when women are in their 30s — can measure types of proteins in the blood that may.

Read More